Benzodiazepine-induced hippocampal CA1 neuron α-amino-3-hydroxy-5- methylisoxasole-4-propionic acid (AMPA) receptor plasticity linked to severity of withdrawal anxiety: Differential role of voltage-gated calcium channels and N-methyl-D-aspartic acid receptors

Behavioural Pharmacology

Volumn 18, Issue 5-6, 2007, Pages 447-460

  Xiang, Kun ^a   Tietz, Elizabeth I ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Anxiety; Dependence; Drug abuse; Glutamate; L type voltagegated calcium channel; Rat

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; BENZODIAZEPINE; CALCIUM CHANNEL L TYPE; DIZOCILPINE; FLURAZEPAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NIMODIPINE; VOLTAGE GATED CALCIUM CHANNEL;

AMPLITUDE MODULATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; DRUG WITHDRAWAL; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; MALE; MEMBRANE CURRENT; MINIATURE ENDPLATE POTENTIAL; NEGATIVE FEEDBACK; NERVE CELL PLASTICITY; NONHUMAN; RAT; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; UPREGULATION; WITHDRAWAL SYNDROME;

ANIMALS; ANXIETY; BENZODIAZEPINES; CALCIUM CHANNELS, L-TYPE; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOWN-REGULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; FLURAZEPAM; HIPPOCAMPUS; MALE; NEURONAL PLASTICITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34548413741     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3282d28f2b     Document Type: Article

References (69)

1. Allison C, Pratt JA (2003). Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol Ther 98:171-195.
2. Allison C, Dunworth SJ, Stephens DN, Pratt JA (1999). Involvement of AMPA-receptors in benzodiazepine withdrawal and sensitization processes. Behav Pharmacol 10 (Suppl 1):S2.
3. Boehm J, Malinow R (2005). AMPAR receptor phosphorylation during synaptic plasticity. Biochem Soc Trans 33:1354-1356.
4. Borroni AM, Fichtenholtz H, Woodside BL, Teyler TJ (2000). Role of voltage-dependent calcium channel long-term potentiation (LTP) and NMDA LTP in spatial memory. J Neurosci 20:9272-9276.
5. A receptor activation and intracellular calcium elevation. Neuron 44:701-713.
6. Chugh Y, Saha N, Sankaranarayanan A, Sharma PL (1992). Effect of peripheral administration of cinnarizine and verapamil on the abstinence syndrome in diazepam-dependent rats. Psychopharmacology 106:127-130.
7. Das P, Bell-Horner CL, Huang RQ, Raut A, Gonzales EB, Chen ZL, et al. (2004). Inhibition of type A GABA receptors by L-type calcium channel blockers. Neuroscience 124:195-206.
8. Degroot A, Kashluba S, Treit D (2001). Septal GABAergic and hippocampus cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Pharmacol Biochem Behav 69:391-399.
9. Dolin SJ, Path TL, Rabbani M, Siarey RJ, Bowhay AR, Little HJ (1990). Nitrendipine decreases benzodiazepine withdrawal seizures but not the development of benzodiazepine tolerance or withdrawal signs. Br J Pharmacol 101:691-697.
10. Dunworth SJ, Stephens DN (1998). Sensitisation to repeated withdrawal, in mice treated chronically with diazepam, is blocked by an NMDA receptor antagonist. Psychopharmacology 136:308-310.
11. Gallager DW, Malcolm AB, Anderson SA, Gonsalves SF (1985). Continuous release of diazepam: electrophysiological, biochemical and behavioral consequences. Brain Res 342:26-36.
12. Ganouni SE, Hanoun N, Boni C, Tazi A, Hmon F (2004). Prevention of diazepam withdrawal syndrome by nifedipine-behavioural and neurochemical studies. Pharmacol, Biochem Behav 79:269-277.
13. 2+ channel currents in Xenopus oocytes injected with rat heart RNA. J Basic Clin Physiol Pharmacol 3:81-97.
14. Griffiths RR, Johnson MW (2005). Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J Clin Psych 66 (Suppl 9):31-41.
15. Groth RD, Dunbar RL, Mermelstein PG (2003). Calcineurin regulation of neuronal plasticity. Biochem Biophys Res Commun 311:1159-1171.
16. Gupta MB, Nath C, Patnaik GK, Saxena RC (1996). Effect of calcium channel blockers on withdrawal syndrome of lorazepam in rats. Indian J Med Res 103:310-314.
17. 2+ channels. Mol Pharmacol 50:1284-1294.
18. Houlihan LM, Slater EY, Beadle DJ, Lukas RJ, Bermudez I (2000). Effects of diltiazem on human nicotinic acetylcholine and GABA(A) receptors. Neuropharmacology 39:2533-2542.
19. Ishizawa Y, Furuya K, Yamagishi S, Dohi S (1997). Non-GABAergic effects of midazolam, diazepam and flumazenil on voltage-dependent ion currents in NG108-15 cells. NeuroReport 8:2635-2638.
20. Izzo E, Auta J, Impagnatiello F, Pesold C, Guidotti A, Costa E (2001). Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines. Proc Natl Acad Sci U S A 98:3483-3488.
21. Jackson A, Meas AN, Stephens DN (2000). Behavioural effects of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-receptor antagonists and their relevance to substance abuse. Pharmacol Ther 88:59-76.
22. Jang CG, Oh S, Ho IK (1998). Changes in NMDAR2 subunit mRNA levels during pentobarbital tolerance/withdrawal in the rat brain: an in situ hybridization study. Neurochem Res 23:1371-1377.
23. 3H]AMPA receptor binding and in situ hybridization of AMPA sensitive glutamate receptor A (GluR-A) subunits following morphine withdrawal in the rat brain. Brain Res Bull 52:217-221.
24. Koff JM, Pritchard GA, Greenblatt DJ, Miller LG (1997). The NMDA receptor competitive antagonist CPP modulates benzodiazepine tolerance and discontinuation. Pharmacololgy 55:217-227.
25. Lamprea MR, Cardenas FP, Silveira R, Walsh TJ, Morato S (2003). Effects of septal cholinergic lesion on rat exploratory behavior in an open-field. Braz J Med Biol Res 36:233-238.
26. Lau CE, Falk JL, Dolan S, Tang M (1987). Simultaneous determination of lorazepam and five metabolites in serum by high-preformance liquid chromatography and its application to pharmacokinetic studies in rats. J Chromatogr 423:251-259.
27. Little HJ (1999). The contribution of electrophysiology to knowledge of the acute and chronic effects of ethanol. Pharmacol Ther 84:333-353.
28. Malenka RC (2003). Synaptic plasticity and AMPA receptor trafficking. Ann N Y Acad Sci 1003:1-11.
29. Malinow R (2003). AMPA receptor trafficking and long-term potentiation. Philos Trans R Soc Lond B Biol Sci 358:707-714.
30. Marty A, Liano I (2006). Excitatory effects of GABA in established brain networks. Trends Neurosci 28:284-289.
31. Millan MJ (2003). The neurobiology and control of anxious states. Prog Neurobiol 70:83-244.
32. Molleman A, Little HJ (1995). Increases in non-N-methyl-D-aspartate glutamatergic transmission, but no change in gamma-aminobutyric acidB transmission, in CA1 neurons during withdrawal from in vivo chronic ethanol treatment. J Pharmacol Exp Ther 274:1035-1041.
33. Morgan SL, Teyler TJ (1999). VDCCs and NMDARs underlie two forms of LTP in CA1 hippocampus in vivo. J Neurophysiol 82:736-740.
34. Nestler EJ (2005). Is there a common molecular pathway for addiction? Nat Neurosci 8:1445-1449.
35. Perez-Otano I, Ehlers MD (2005). Homeostatic plasticity and NMDA receptor trafficking. Trends Neurosci 28:229-238.
36. Podhorna J (2002). The experimental pharmacotherapy of benzodiazepine withdrawal. Current Pharmaceut Design 8:23-43.
37. Pourmotabbed A, Motamedi F, Fathollahi Y, Mansouri FA, Semnanian S (1998). Involvement of NMDA receptors and voltage-dependent calcium channels on augmentation of long-term potentiation in hippocampal CA1 area of morphine dependent rats. Brain Res 804:125-134.
38. 2+ flux after withdrawal from chronic barbiturate treatment. E J Pharmacol 364:221-227.
39. Rajadhyksha AM, Kosofsky BE (2005). Psychostimulants, L-type calcium channels, kinases, and phosphatases. Neuroscientist 11:494-502.
40. Reichling DB, Kyrosis A, Wang J, MacDermott AB (1994). Mechanisms of GABA and glycine depolarization-induced calcium transients in rat dorsal horn neurons. J Physiol 476:411-421.
41. Reuveny E, Twombly DA, Narahashi T (1993). Chlordiazepoxide block of two types of calcium channels in neuroblastoma cells. J Pharmacol Exp Ther 264:22-28.
42. 2+ channel than corresponding cerebral vessels. Clin Exper Hyper 24:715-726.
43. Rodgers RJ, Dalvi A (1997). Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev. 21:801-810.
44. Rodrigues SM, Schafe GE, LeDoux JE (2004). Molecular mechanisms underlying emotional learning and memory in the lateral amygadala. Neuron 44: 75-91.
45. Sanchis-Segura C, Borchardt T, Vengetina V, Zghoul T, Bachteler D, Gass P, Sprengel R, Spanagel R (2006). Involvement of the AMPA receptor-C subunit in alcohol-seeking behavior and relapse. J Neurosci 26:1231-1238.
46. Scriabine A, Schuurman T, Traber J (1989). Pharmacological basis for the use of nimodipine in central nervous system disorders. FASEB J 3:1799-1806.
47. Shi SH, Hayashi Y, Petralia RS, Zaman SH, Wenthold RJ, Svoboda K, Malinow R (1999). Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science 284:1755-1757.
48. Shinnick-Gallagher P, McKernan MG, Xie J, Zinebi F (2003). L-type voltage-gated calcium channels are involved in the in vivo and in vitro expression of fear conditioning. Ann NY Acad Sci 985:135-149.
49. Song I, Huganir RL (2002). Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci 25:578-588.
50. Song J, Shen G, Greenfield LJ Jr, Tietz EI (2007). Benzodiazepine withdrawal-induced glutamatergic plasticity involves upregulation of GluR1-containing AMPA Receptors in hippocampal CA1 Neurons. J Pharmacol Exp Ther 322 (in press).
51. Stephens DN (1995). A glutamatergic hypothesis of drug dependence. Behav Pharmacol 6:425-446.
52. Steppuhn KG, Turski L (1993). Diazepam dependence prevented by glutamate antagonists. Proc Natl Sci U S A 90:6889-6893.
53. Taft WC, DeLorenzo RJ (1984). Micromolar-affinity benzodiazepine receptors regulate voltage-sensitive calcium channels in nerve terminal preparations. Proc Natl Acad Sci 81:3118-3122.
54. Tzschentke TM, Schmidt WJ (2003). Glutamatergic mechanisms in addiction. Mol Psychiatry 8:373-382.
55. Van Sickle B, Tietz EI (2002). Selective enhancement of AMPA receptor-mediated function in hippocampal CA1 neurons from chronic benzodiazepine-treated rats. Neuropharmacology 43:11-27.
56. Van Sickle B, Cox A, Schak K, John GL, Tietz EI (2002). Chronic benzodiazepine administration alters hippocampal CA1 neuron excitability: NMDA receptor function and expression. Neuropharmacology 43:595-606.
57. Van Sickle B, Xiang K, Tietz EI (2004). Transient plasticity of hippocampus CA1 neuron glutamate receptors contributes to benzodiazepine withdrawal anxiety. Neuropsychopharmacology 29:1994-2006.
58. Vekovischeva OY, Zamanillo D, Echenko O, Seppala T, Uusi-Oukari M, Honkanen A, et al. (2001). Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits. J Neurosci 21:4451-4459.
59. Watson WP, Little HJ (2002). Selectivity of the protective effects of dihydropyridine calcium channel antagonist against the ethanol withdrawal syndrome. Brain Res 930:111-122.
60. Whittington MA, Little HJ (1993). Changes in voltage-operated calcium channels modify ethanol withdrawal hyperexcitability in mouse hippocampal slices. Exp Physiol 78:347-370.
61. Whittington MA, Lambert JD, Little HJ (1995). Increased NMDA receptor and calcium channel activity underlying ethanol withdrawal hyperexcitability. Alcohol Alcohol 30:105-14.
62. Xia Z, Storm DR (2005). The role of calmodulin as a signal integrator for synaptic plasticity. Nat Rev Neurosci. 6:267-276.
63. Xiang K, Giovannucci DR, Greenfield Jr LJ, Tietz EI (2006.) Enhanced calcium entry through L-type voltage-gated calcium channels contributes to AMPA receptor plasticity in hippocampal CA1 neurons after chronic benzodiazepine treatment. Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, Online.
64. Xie XH, Tietz EI (1992). Reduction in potency of selective gamma-aminobutyric acid A agonists and diazepam in CA1 region of in vitro hippocampal slices from chronic flurazepam-treated rats. J Pharmacol Exp Ther 262:204-211.
65. - driving force. Synapse 25:125-136.
66. Zeng X, Tietz EI (2000). Role of bicarbonate ion in mediating decreased synaptic conductance in benzodiazepine tolerant hippocampal CA1 pyramidal neurons. Brain Res 868:202-214.
67. Zeng X, Xie XH, Tietz EI (1995). Reduction of GABA-mediated inhibitory postsynaptic potentials in hippocampus CA1 pyramidal neurons following oral flurazepam administration. Neuroscience 66:87-99.
68. Zhong W, Dong Z, Tian M, Cao J, Xu T, Xu L, Luo J (2006). Opiate withdrawal induces dynamic expressions of AMPA receptors and its regulatory molecule CaMKIIalpha in hippocampal synapses. Life Sci 79:861-869.
69. Zinebi F, Xie JG, Liu J, Russell RT, Gallagher JP, McKernan MG, Shinnick-Gallagher P (2003). NMDA currents and receptor protein are downregulated in the amygdala during maintenance of fear memory. J Neurosci 23:10283-10291.